Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Pouya, Alireza ^a   Satarian, Leila ^a,b   Kiani, Sahar ^a   Javan, Mohammad ^a,b   Baharvand, Hossein ^a,c  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GALACTOSYLCERAMIDASE; MYELIN BASIC PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN A2B5; PROTEIN O4; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; NERVE PROTEIN; OLIG2 PROTEIN, HUMAN; SOX10 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CELL POPULATION; CELL SELECTION; CELL SPECIFICITY; CONTROLLED STUDY; DEMYELINATION; EMBRYOID BODY; EMBRYONIC STEM CELL; EVOKED VISUAL RESPONSE; IMMUNOFLUORESCENCE TEST; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; OPTIC CHIASM; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; SYMPTOM; THERAPY EFFECT; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DEMYELINATING DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT; STEM CELL; TRANSPLANTATION; TREATMENT OUTCOME; XENOGRAFT;

RATTUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; DEMYELINATING DISEASES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; OPTIC CHIASM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXE TRANSCRIPTION FACTORS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 81355142740     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027925     Document Type: Article

References (56)

1. Martino G, Franklin RJ, Van Evercooren AB, Kerr DA, (2010) Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol 6: 247-255.
2. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
3. Stadtfeld M, Hochedlinger K, (2010) Induced pluripotency: history, mechanisms, and applications. Genes Dev 24: 2239-2263.
4. Gonzalez F, Boue S, Belmonte JC, (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12: 231-242.
5. Plath K, Lowry WE, (2011) Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 12: 253-265.
6. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, et al. (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68-73.
7. Zhu H, Lensch MW, Cahan P, Daley GQ, (2011) Investigating monogenic and complex diseases with pluripotent stem cells. Nat Rev Genet 12: 266-275.
8. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280.
9. Nemati S, Hatami M, Kiani S, Hemmesi K, Gourabi H, et al. (2010) Long-term Self-Renewable Feeder-Free Human Induced Pluripotent Stem Cell-derived Neural Progenitors. Stem Cells Dev: [Epub ahead of print].
10. Onorati M, Camnasio S, Binetti M, Jung CB, Moretti A, et al. (2010) Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells. Mol Cell Neurosci 43: 287-295.
11. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, et al. (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 107: 12704-12709.
12. Crocker SJ, Bajpai R, Moore CS, Frausto RF, Brown GD, et al. (2011) Intravenous Administration of Human ES-derived Neural Precursor Cells Attenuates Cuprizone-induced CNS Demyelination. Neuropathol Appl Neurobiol [Epub ahead of print].
13. Erceg S, Ronaghi M, Oria M, Rosello MG, Arago MA, et al. (2010) Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 28: 1541-1549.
14. Cloutier F, Siegenthaler MM, Nistor G, Keirstead HS, (2006) Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med 1: 469-479.
15. Faulkner J, Keirstead HS, (2005) Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl Immunol 15: 131-142.
16. Zhang YW, Denham J, Thies RS, (2006) Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 15: 943-952.
17. Hu BY, Zhang SC, (2009) Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc 4: 1295-1304.
18. Hu BY, Du ZW, Li XJ, Ayala M, Zhang SC, (2009) Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136: 1443-1452.
19. Hu Z, Li T, Zhang X, Chen Y, (2009) Hepatocyte growth factor enhances the generation of high-purity oligodendrocytes from human embryonic stem cells. Differentiation 78: 177-184.
20. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, et al. (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25: 4694-4705.
21. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS, (2005) Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49: 385-396.
22. Sharp J, Frame J, Siegenthaler M, Nistor G, Keirstead HS, (2010) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 28: 152-163.
23. Kerr CL, Letzen BS, Hill CM, Agrawal G, Thakor NV, et al. (2010) Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 120: 305-313.
24. Hu BY, Du ZW, Zhang SC, (2009) Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4: 1614-1622.
25. Tokumoto Y, Ogawa S, Nagamune T, Miyake J, (2010) Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro. J Biosci Bioeng 109: 622-628.
26. Czepiel M, Balasubramaniyan V, Schaafsma W, Stancic M, Mikkers H, et al. (2011) Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia 59: 882-892.
27. Hatch MN, Nistor G, Keirstead HS, (2009) Derivation of high-purity oligodendroglial progenitors. Methods Mol Biol 549: 59-75.
28. Totonchi M, Taei A, Seifinejad A, Tabebordbar M, Rassouli H, et al. (2010) Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. Int J Dev Biol 54: 877-886.
29. Pakzad M, Totonchi M, Taei A, Seifinejad A, Hassani SN, et al. (2010) Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Rev 6: 96-107.
30. Baharvand H, Ashtiani SK, Taee A, Massumi M, Valojerdi MR, et al. (2006) Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ 48: 117-128.
31. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
32. Paxinos G, Watson C, (2007) The rat brain in stereotaxic coordinates. Academic Press/Elsevier 6th ed.
33. Hall SM, (1972) The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 10: 535-546.
34. Woodruff RH, Franklin RJ, (1999) The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination. Neuropathol Appl Neurobiol 25: 226-235.
35. Mozafari S, Sherafat MA, Javan M, Mirnajafi-Zadeh J, Tiraihi T, (2010) Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Res 1351: 50-56.
36. Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, et al. (2009) Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 5: 396-408.
37. Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, et al. (2008) Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 214: 347-361.
38. Hudnell HK, Boyes WK, Otto DA, (1990) Rat and human visual-evoked potentials recorded under comparable conditions: a preliminary analysis to address the issue of predicting human neurotoxic effects from rat data. Neurotoxicol Teratol 12: 391-398.
39. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
40. Zhou Q, Wang S, Anderson DJ, (2000) Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25: 331-343.
41. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, et al. (2001) Neural progenitors from human embryonic stem cells. Nat Biotechnol 19: 1134-1140.
42. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M, (1998) Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18: 237-250.
43. Takebayashi H, Yoshida S, Sugimori M, Kosako H, Kominami R, et al. (2000) Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 99: 143-148.
44. Zhang SC, (2001) Defining glial cells during CNS development. Nat Rev Neurosci 2: 840-843.
45. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA, (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19: 1129-1133.
46. Cai Z, Pang Y, Xiao F, Rhodes PG, (2001) Chronic ischemia preferentially causes white matter injury in the neonatal rat brain. Brain Res 898: 126-135.
47. Durand B, Raff M, (2000) A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22: 64-71.
48. Brolen G, Sivertsson L, Bjorquist P, Eriksson G, Ek M, et al. (2010) Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J Biotechnol 145: 284-294.
49. Espinosa-Jeffrey A, Wakeman DR, Kim SU, Snyder EY, de Vellis J, (2009) Culture system for rodent and human oligodendrocyte specification, lineage progression, and maturation. Curr Protoc Stem Cell Biol Chapter 2: Unit 2D 4.
50. Buchet D, Baron-Van Evercooren A, (2009) In search of human oligodendroglia for myelin repair. Neurosci Lett 456: 112-119.
51. Allt G, Ghabriel MN, Sikri K, (1988) Lysophosphatidyl choline-induced demyelination. A freeze-fracture study. Acta Neuropathol 75: 456-464.
52. Dousset V, Brochet B, Vital A, Gross C, Benazzouz A, et al. (1995) Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 16: 225-231.
53. Bull ND, Irvine KA, Franklin RJ, Martin KR, (2009) Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest Ophthalmol Vis Sci 50: 4244-4253.
54. Einstein O, Friedman-Levi Y, Grigoriadis N, Ben-Hur T, (2009) Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci 29: 15694-15702.
55. Gore A, Li Z, Fung HL, Young JE, Agarwal S, et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
56. Zhao T, Zhang ZN, Rong Z, Xu Y, (2011) Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.